Endophenotypes and serotonergic polymorphisms associated with treatment response in obsessivecompulsive disorder

Clinics

Volumn 67, Issue 4, 2012, Pages 335-340

  Corregiari, Fábio M ^a   Bernik, Márcio ^a   Cordeiro, Quirino ^a   Vallada, Homero ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Challenge test; Citalopram; Pharmacogenetics; Serotonin receptor subtype 1D ; Serotonin receptor subtype 2A

Indexed keywords

CITALOPRAM; SEROTONIN RECEPTOR; SEROTONIN UPTAKE INHIBITOR;

ADOLESCENT; ADULT; AGED; ARTICLE; CASE CONTROL STUDY; DRUG EFFECT; ENDOCRINE SYSTEM; FEMALE; GENETIC MARKER; GENETIC POLYMORPHISM; GENETICS; HUMAN; MALE; MIDDLE AGED; OBSESSIVE COMPULSIVE DISORDER; TIME; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; CITALOPRAM; ENDOCRINE SYSTEM; FEMALE; GENETIC MARKERS; HUMANS; MALE; MIDDLE AGED; OBSESSIVE-COMPULSIVE DISORDER; POLYMORPHISM, GENETIC; RECEPTORS, SEROTONIN; SEROTONIN UPTAKE INHIBITORS; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84860165960     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.6061/clinics/2012(04)06     Document Type: Article

References (24)

1. Stein DJ. Obsessive-compulsive disorder. Lancet. 2002 Aug 3;360(9330):397-405, http://dx.doi.org/10.1016/S0140-6736(02)09620-4.
2. Pigott TA, Seay SM. A review of the efficacy of selective serotonin reuptake inhibitors in obsessive-compulsive disorder. J Clin Psychiatry 1999;60(2):101-6. CLINICS 2012;67(4):335-340
3. Collier DA. Pharmacogenetics in psychosis. Drug News Perspect. 2003;16(3):159-65, http://dx.doi.org/10.1358/dnp.2003.16.3.737958.
4. Corregiari FM, Gattaz WF, Bernik M. Acute hormonal changes after IV citalopram and treatment response in OCD. Psychopharmacology (Berl). 2007 Sep;193(4):487-94, http://dx.doi.org/10.1007/s00213-007-0793-0.
5. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994.
6. Kim SW, Dysken MW, Kuskowski M. The Yale-Brown Obsessive-Compulsive Scale: a reliability and validity study. Psychiatry Res. 1990;34(1):99-106, http://dx.doi.org/10.1016/0165-1781(90)90061-9.
7. Leon AC, Shear MK, Portera L, Klerman GL. Assessing impairment in patients with panic disorder: the Sheehan Disability Scale. Soc Psychiatry Psychiatr Epidemiol. 1992;27(2):78-82, http://dx.doi.org/10.1007/BF00788510.
8. Miller SA, Dykes DD, Polesky HF. A single salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16:1215, http://dx.doi.org/10.1093/nar/16.3.1215.
9. Mundo E, Richter MA, Zai G, Sam F, McBride J, Macciardi F, et al. 5HT1Db Receptor gene implicated in the pathogenesis of Obsessive-Compulsive Disorder: further evidence from a family-based association study. Mol Psychiatry. 2002;7(7):805-9, http://dx.doi.org/10.1038/sj.mp.4001059.
10. Warren JT Jr, Peacock ML, Rodriguez LC, Fink JK. An MspI polymorphism in the human serotonin receptor gene (HTR2): detection by DGGE and RFLP analysis. Hum Mol Genet. 1993;2(3):338, http://dx.doi.org/10.1093/hmg/2.3.338.
11. Association between clozapine response and allelic variation in 5-HT2A receptor gene. Lancet. 1995;346(8970):281-2.
12. Ott J. Utility Programs for Analysis of Genetic Linkage. 1988.
13. Denys D, Van Nieuwerburgh F, Deforce D, Westenberg HG. Prediction of response to paroxetine and venlafaxine by serotonin-related genes in obsessive-compulsive disorder in a randomized, double-blind trial. J Clin Psychiatry. 2007;68(5):747-53, http://dx.doi.org/10.4088/JCP.v68n0512.
14. Cavallini MC, Bella D, Pasquale L, Henin M, Bellodi L. 5HT2C CYS23/ SER23 polymorphism is not associated with obsessive-compulsive disorder. Psychiatry Res. 1998;9;77(2):97-104, http://dx.doi.org/10.1016/S0165-1781(97)00151-0.
15. Ziegler A, Van Steen K, Wellek S. Investigating Hardy-Weinberg equilibrium in case-control or cohort studies or meta-analysis. Breast Cancer Res Treat. 2011;128(1):197-201, http://dx.doi.org/10.1007/s10549-010-1295-z.
16. Szeszko JS, Howson JM, Cooper JD, Walker NM, Twells RC, Stevens HE, et al. Analysis of polymorphisms of the interleukin-18 gene in type 1 diabetes and Hardy-Weinberg equilibrium testing. Diabetes. 2006;55(2):559-62, http://dx.doi.org/10.2337/diabetes.55.02.06.db05-0826.
17. Hounie AG, Cappi C, Cordeiro Q, Sampaio AS, Moraes I, Rosário MC, et al. TNF-alpha polymorphisms are associated with obsessivecompulsive disorder. Neurosci Lett. 2008;442(2):86-90, http://dx.doi.org/10.1016/j.neulet.2008.07.022.
18. Meira-Lima I, Shavitt RG, Miguita K, Ikenaga E, Miguel EC, Vallada H. Association analysis of the catechol-o-methyltransferase (COMT), serotonin transporter (5-HTT) and serotonin 2A receptor (5HT2A) gene polymorphisms with obsessive-compulsive disorder. Genes Brain Behav. 2004;3(2):75-9, http://dx.doi.org/10.1046/j.1601-1848.2003.0042.x.
19. Miguita K, Cordeiro Q, Shavitt RG, Miguel EC, Vallada H. Association study between genetic monoaminergic polymorphisms and OCD response to clomipramine treatment. Arq Neuropsiquiatr. 2011;69(2B): 283-7, http://dx.doi.org/10.1590/S0004-282X2011000300003.
20. Chopin P, Moret C, Briley M. Neuropharmacology of 5-hydroxytryptamine1B/D receptor ligands. Pharmacol Ther. 1994;62(3):385-405, http://dx.doi.org/10.1016/0163-7258(94)90051-5.
21. Blier P, de Montigny C, Chaput Y. Modifications of the serotonin system by antidepressant treatments: implications for the therapeutic response in major depression. J Clin Psychopharmacol. 1987;7(6 Suppl):24S-35S.
22. Mongeau R, Marsden CA. Effect of imipramine treatments on the 5-HT1A-receptor-mediated inhibition of panic-like behaviours in rats. Psychopharmacology (Berl). 1997;131(4):321-8, http://dx.doi.org/10.1007/s002130050299.
23. Silva MA, Cordeiro Q, Miracca EC, Guindalini C, Vallada H. Distribution of alleles of the VNTR polymorphism in the 39-untranslated region of the DAT1 gene (SLC6A3) in São Paulo/Brazil and its importance to genetic studies of neuropsychiatric disorders in ethically admixed populations. Rev Med Chil. 2005;133(11):1392-3.
24. Parra FC, Amado RC, Lambertucci JR, Rocha J, Antunes CM, Pena SD. Color and genomic ancestry in Brazilians. Proc Natl Acad Sci U S A. 2003;100(1):177-82, http://dx.doi.org/10.1073/pnas.0126614100.